LAMEA Genomics In Cancer Care Market Size, Share & Trends Analysis Report By Application, By Product (Instruments, Consumables, Services), By Technology, By Country and Growth Forecast, 2024

List of Tables

The Latin America, Middle East and Africa Genomics In Cancer Care Market would witness market growth of 17.4% CAGR during the forecast period (2024-2031).

The Brazil market dominated the LAMEA Genomics In Cancer Care Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $976.1 million by 2031. The Argentina market is showcasing a CAGR of 18.3% during (2024 - 2031). Additionally, The UAE market would register a CAGR of 16.5% during (2024 - 2031).

The growing body of evidence demonstrating the clinical benefits of genomic-based approaches has driven adoption in cancer care. Studies showing improved treatment outcomes, better response rates, and reduced adverse effects associated with genomics-guided therapies have encouraged healthcare providers to incorporate genomic testing into their practice.

Moreover, educational initiatives and training programs for healthcare providers are promoting the adoption of genomics in cancer care. These programs aim to enhance knowledge and skills related to genomic testing, interpretation of results, and integration of genomic information into clinical decision-making. Increased provider education facilitates the adoption of genomics-based approaches in clinical practice.

New healthcare technologies in Saudi Arabia enhance genomic research capabilities, including advanced sequencing technologies and bioinformatics tools. This improvement accelerates the development of genomic solutions for cancer diagnosis and treatment, driving growth in the genomics market. According to the International Trade Administration (ITA), under Vision 2030, the Saudi Arabian Government plans to invest over $65 billion to develop the country's healthcare infrastructure, reorganize and privatize health services and insurance, launch 21 "health clusters" across the country, and expand the provision of e-health services.

Based on Application, the market is segmented into Diagnostics, Personalized Medicine, Drug Discovery & Development, and Research. Based on Product, the market is segmented into Instruments, Consumables, Services. Based on Technology, the market is segmented into PCR, Genome Sequencing, Microarrays, Nuclei Acid Extraction & Purification, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

List of Key Companies Profiled

Agilent Technologies, Inc.
F. Hoffmann-La Roche Ltd.
Danaher Corporation (Beckman Coulter, Inc.)
Abbott Laboratories
Bio-Rad Laboratories, Inc.
GE HealthCare Technologies, Inc.
Quest Diagnostics Incorporated
Revvity, Inc.
Eurofins Scientific SE
Hologic, Inc.

LAMEA Genomics In Cancer Care Market Report Segmentation

By Application

Diagnostics
Personalized Medicine
Drug Discovery & Development
Research

By Product

Instruments
Consumables
Services

By Technology

PCR
Genome Sequencing
Microarrays
Nuclei Acid Extraction & Purification
Others

By Country

Brazil
Argentina
UAE
Saudi Arabia
South Africa
Nigeria
Rest of LAMEA

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 LAMEA Genomics In Cancer Care Market, by Application
- 1.4.2 LAMEA Genomics In Cancer Care Market, by Product
- 1.4.3 LAMEA Genomics In Cancer Care Market, by Technology
- 1.4.4 LAMEA Genomics In Cancer Care Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance

2.1 Key Highlights

Chapter 3. Market Overview

3.1 Introduction
- 3.1.1 Overview
  - 3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges

Chapter 4. Competition Analysis - Global

4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
- 4.2.1 Partnerships, Collaborations and Agreements
- 4.2.2 Product Launches and Product Expansions
- 4.2.3 Acquisition and Mergers
4.3 Market Share Analysis, 2023
4.4 Top Winning Strategies
- 4.4.1 Key Leading Strategies: Percentage Distribution (2020-2024)
- 4.4.2 Key Strategic Move: (Mergers and Acquisitions: 2021, Jan - 2023, Jan) Leading Players
4.5 Porter Five Forces Analysis

Chapter 5. LAMEA Genomics In Cancer Care Market by Application

5.1 LAMEA Diagnostics Market by Country
5.2 LAMEA Personalized Medicine Market by Country
5.3 LAMEA Drug Discovery & Development Market by Country
5.4 LAMEA Research Market by Country

Chapter 6. LAMEA Genomics In Cancer Care Market by Product

6.1 LAMEA Instruments Market by Country
6.2 LAMEA Consumables Market by Country
6.3 LAMEA Services Market by Country

Chapter 7. LAMEA Genomics In Cancer Care Market by Technology

7.1 LAMEA PCR Market by Country
7.2 LAMEA Genome Sequencing Market by Country
7.3 LAMEA Microarrays Market by Country
7.4 LAMEA Nuclei Acid Extraction & Purification Market by Country
7.5 LAMEA Others Market by Country

Chapter 8. LAMEA Genomics In Cancer Care Market by Country

8.1 Brazil Genomics In Cancer Care Market
- 8.1.1 Brazil Genomics In Cancer Care Market by Application
- 8.1.2 Brazil Genomics In Cancer Care Market by Product
- 8.1.3 Brazil Genomics In Cancer Care Market by Technology
8.2 Argentina Genomics In Cancer Care Market
- 8.2.1 Argentina Genomics In Cancer Care Market by Application
- 8.2.2 Argentina Genomics In Cancer Care Market by Product
- 8.2.3 Argentina Genomics In Cancer Care Market by Technology
8.3 UAE Genomics In Cancer Care Market
- 8.3.1 UAE Genomics In Cancer Care Market by Application
- 8.3.2 UAE Genomics In Cancer Care Market by Product
- 8.3.3 UAE Genomics In Cancer Care Market by Technology
8.4 Saudi Arabia Genomics In Cancer Care Market
- 8.4.1 Saudi Arabia Genomics In Cancer Care Market by Application
- 8.4.2 Saudi Arabia Genomics In Cancer Care Market by Product
- 8.4.3 Saudi Arabia Genomics In Cancer Care Market by Technology
8.5 South Africa Genomics In Cancer Care Market
- 8.5.1 South Africa Genomics In Cancer Care Market by Application
- 8.5.2 South Africa Genomics In Cancer Care Market by Product
- 8.5.3 South Africa Genomics In Cancer Care Market by Technology
8.6 Nigeria Genomics In Cancer Care Market
- 8.6.1 Nigeria Genomics In Cancer Care Market by Application
- 8.6.2 Nigeria Genomics In Cancer Care Market by Product
- 8.6.3 Nigeria Genomics In Cancer Care Market by Technology
8.7 Rest of LAMEA Genomics In Cancer Care Market
- 8.7.1 Rest of LAMEA Genomics In Cancer Care Market by Application
- 8.7.2 Rest of LAMEA Genomics In Cancer Care Market by Product
- 8.7.3 Rest of LAMEA Genomics In Cancer Care Market by Technology

Chapter 9. Company Profiles

9.1 Agilent Technologies, Inc.
- 9.1.1 Company Overview
- 9.1.2 Financial Analysis
- 9.1.3 Segmental and Regional Analysis
- 9.1.4 Research & Development Expense
- 9.1.5 Recent strategies and developments:
  - 9.1.5.1 Acquisition and Mergers:
- 9.1.6 SWOT Analysis
9.2 F. Hoffmann-La Roche Ltd.
- 9.2.1 Company Overview
- 9.2.2 Financial Analysis
- 9.2.3 Segmental and Regional Analysis
- 9.2.4 Research & Development Expense
- 9.2.5 Recent strategies and developments:
  - 9.2.5.1 Partnerships, Collaborations, and Agreements:
  - 9.2.5.2 Product Launches and Product Expansions:
- 9.2.6 SWOT Analysis
9.3 Danaher Corporation (Beckman Coulter, Inc.)
- 9.3.1 Company Overview
- 9.3.2 Financial Analysis
- 9.3.3 Segmental and Regional Analysis
- 9.3.4 Research & Development Expense
- 9.3.5 Recent strategies and developments:
  - 9.3.5.1 Partnerships, Collaborations, and Agreements:
- 9.3.6 SWOT Analysis
9.4 Abbott Laboratories
- 9.4.1 Company Overview
- 9.4.2 Financial Analysis
- 9.4.3 Segmental and Regional Analysis
- 9.4.4 Research & Development Expense
- 9.4.5 SWOT Analysis
9.5 Bio-Rad laboratories, Inc.
- 9.5.1 Company Overview
- 9.5.2 Financial Analysis
- 9.5.3 Segmental and Regional Analysis
- 9.5.4 Research & Development Expenses
- 9.5.5 Recent strategies and developments:
  - 9.5.5.1 Partnerships, Collaborations, and Agreements:
  - 9.5.5.2 Product Launches and Product Expansions:
- 9.5.6 SWOT Analysis
9.6 GE HealthCare Technologies, Inc.
- 9.6.1 Company Overview
- 9.6.2 Financial Analysis
- 9.6.3 Segmental and Regional Analysis
- 9.6.4 Research & Development Expenses
- 9.6.5 Recent strategies and developments:
  - 9.6.5.1 Partnerships, Collaborations, and Agreements:
- 9.6.6 SWOT Analysis
9.7 Quest Diagnostics Incorporated
- 9.7.1 Company Overview
- 9.7.2 Financial Analysis
- 9.7.3 Segmental Analysis
- 9.7.4 SWOT Analysis
9.8 Revvity, Inc.
- 9.8.1 Company Overview
- 9.8.2 Financial Analysis
- 9.8.3 Segmental and Regional Analysis
- 9.8.4 Research & Development Expenses
- 9.8.5 Recent strategies and developments:
  - 9.8.5.1 Acquisition and Mergers:
- 9.8.6 SWOT Analysis
9.9 Eurofins Scientific SE
- 9.9.1 Company Overview
- 9.9.2 Financial Analysis
- 9.9.3 Regional Analysis
- 9.9.4 SWOT Analysis
9.10. Hologic, Inc.
- 9.10.1 Company Overview
- 9.10.2 Financial Analysis
- 9.10.3 Segmental and Regional Analysis
- 9.10.4 Research & Development Expenses
- 9.10.5 Recent strategies and developments:
  - 9.10.5.1 Acquisition and Mergers:
- 9.10.6 SWOT Analysis

LIST OF TABLES

TABLE 1 LAMEA Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 2 LAMEA Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 3 Partnerships, Collaborations and Agreements- Genomics In Cancer Care Market
TABLE 4 Product Launches And Product Expansions- Genomics In Cancer Care Market
TABLE 5 Acquisition and Mergers- Genomics In Cancer Care Market
TABLE 6 LAMEA Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 7 LAMEA Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 8 LAMEA Diagnostics Market by Country, 2020 - 2023, USD Million
TABLE 9 LAMEA Diagnostics Market by Country, 2024 - 2031, USD Million
TABLE 10 LAMEA Personalized Medicine Market by Country, 2020 - 2023, USD Million
TABLE 11 LAMEA Personalized Medicine Market by Country, 2024 - 2031, USD Million
TABLE 12 LAMEA Drug Discovery & Development Market by Country, 2020 - 2023, USD Million
TABLE 13 LAMEA Drug Discovery & Development Market by Country, 2024 - 2031, USD Million
TABLE 14 LAMEA Research Market by Country, 2020 - 2023, USD Million
TABLE 15 LAMEA Research Market by Country, 2024 - 2031, USD Million
TABLE 16 LAMEA Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 17 LAMEA Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 18 LAMEA Instruments Market by Country, 2020 - 2023, USD Million
TABLE 19 LAMEA Instruments Market by Country, 2024 - 2031, USD Million
TABLE 20 LAMEA Consumables Market by Country, 2020 - 2023, USD Million
TABLE 21 LAMEA Consumables Market by Country, 2024 - 2031, USD Million
TABLE 22 LAMEA Services Market by Country, 2020 - 2023, USD Million
TABLE 23 LAMEA Services Market by Country, 2024 - 2031, USD Million
TABLE 24 LAMEA Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 25 LAMEA Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 26 LAMEA PCR Market by Country, 2020 - 2023, USD Million
TABLE 27 LAMEA PCR Market by Country, 2024 - 2031, USD Million
TABLE 28 LAMEA Genome Sequencing Market by Country, 2020 - 2023, USD Million
TABLE 29 LAMEA Genome Sequencing Market by Country, 2024 - 2031, USD Million
TABLE 30 LAMEA Microarrays Market by Country, 2020 - 2023, USD Million
TABLE 31 LAMEA Microarrays Market by Country, 2024 - 2031, USD Million
TABLE 32 LAMEA Nuclei Acid Extraction & Purification Market by Country, 2020 - 2023, USD Million
TABLE 33 LAMEA Nuclei Acid Extraction & Purification Market by Country, 2024 - 2031, USD Million
TABLE 34 LAMEA Others Market by Country, 2020 - 2023, USD Million
TABLE 35 LAMEA Others Market by Country, 2024 - 2031, USD Million
TABLE 36 LAMEA Genomics In Cancer Care Market by Country, 2020 - 2023, USD Million
TABLE 37 LAMEA Genomics In Cancer Care Market by Country, 2024 - 2031, USD Million
TABLE 38 Brazil Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 39 Brazil Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 40 Brazil Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 41 Brazil Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 42 Brazil Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 43 Brazil Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 44 Brazil Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 45 Brazil Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 46 Argentina Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 47 Argentina Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 48 Argentina Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 49 Argentina Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 50 Argentina Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 51 Argentina Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 52 Argentina Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 53 Argentina Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 54 UAE Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 55 UAE Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 56 UAE Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 57 UAE Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 58 UAE Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 59 UAE Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 60 UAE Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 61 UAE Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 62 Saudi Arabia Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 63 Saudi Arabia Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 64 Saudi Arabia Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 65 Saudi Arabia Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 66 Saudi Arabia Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 67 Saudi Arabia Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 68 Saudi Arabia Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 69 Saudi Arabia Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 70 South Africa Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 71 South Africa Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 72 South Africa Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 73 South Africa Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 74 South Africa Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 75 South Africa Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 76 South Africa Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 77 South Africa Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 78 Nigeria Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 79 Nigeria Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 80 Nigeria Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 81 Nigeria Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 82 Nigeria Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 83 Nigeria Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 84 Nigeria Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 85 Nigeria Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 86 Rest of LAMEA Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 87 Rest of LAMEA Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 88 Rest of LAMEA Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 89 Rest of LAMEA Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 90 Rest of LAMEA Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 91 Rest of LAMEA Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 92 Rest of LAMEA Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 93 Rest of LAMEA Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 94 key Information - Agilent Technologies, Inc.
TABLE 95 Key Information - F. Hoffmann-La Roche Ltd.
TABLE 96 Key Information - Danaher Corporation
TABLE 97 Key Information - Abbott Laboratories
TABLE 98 Key Information - Bio-Rad Laboratories, Inc.
TABLE 99 Key Information - GE HealthCare Technologies, Inc.
TABLE 100 Key information - Quest Diagnostics Incorporated
TABLE 101 Key Information - Revvity, Inc.
TABLE 102 Key Information - Eurofins Scientific SE
TABLE 103 Key Information - Hologic, Inc.

LAMEA Genomics In Cancer Care Market Size, Share & Trends Analysis Report By Application, By Product (Instruments, Consumables, Services), By Technology, By Country and Growth Forecast, 2024 - 2031

Description

Table of Contents